Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Buy

A

Amgen Inc (AMGN)

Biological Products, (no Disgnostic Substances)

https://www.amgen.com

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/17/1983

Market Cap

173,584,133,450

Shares Outstanding

535,179,999

Weighted SO

535,178,027

Total Employees

N/A

Upcoming Earnings

10/29/2024

Similar Tickers

MRK --.--%

ABBV --.--%

GILD --.--%

JNJ --.--%

BMY --.--%

PFE --.--%

LLY --.--%

BIIB --.--%

Beta

0.5800

Last Div

9.0000

Range

248.38-346.85

Chg

-0.0900

Avg Vol

2232283

Mkt Cap

173584133450

Exch

NASDAQ

Country

US

Phone

805 447 1000

DCF Diff

-275.7312

DCF

598.2812

Div Yield

0.0341

P/S

5.6307

EV Multiple

19.9901

P/FV

29.2790

Div Yield %

3.4081

P/E

55.4242

PEG

11.4123

Payout

1.5006

Current Ratio

1.2644

Quick Ratio

0.8928

Cash Ratio

0.4323

DSO

82.0978

DIO

257.0174

Op Cycle

339.1151

DPO

72.8778

CCC

266.2373

Gross Margin

0.6317

Op Margin

0.1974

Pretax Margin

0.1143

Net Margin

0.1015

Eff Tax Rate

0.1121

ROA

0.0344

ROE

0.5041

ROCE

0.0877

NI/EBT

0.8879

EBT/EBIT

0.5792

EBIT/Rev

0.1974

Debt Ratio

0.6891

D/E

10.5730

LT Debt/Cap

0.9060

Total Debt/Cap

0.9136

Int Coverage

3.8133

CF/Debt

0.1029

Equity Multi

15.3430

Rec Turnover

4.4459

Pay Turnover

5.0084

Inv Turnover

1.4201

FA Turnover

5.0563

Asset Turnover

0.3391

OCF/Share

12.0037

FCF/Share

10.2067

Cash/Share

17.3203

OCF/Sales

0.2091

FCF/OCF

0.8503

CF Coverage

0.1029

ST Coverage

1.1661

CapEx Coverage

6.6798

Div&CapEx Cov

1.1385

P/BV

29.2790

P/B

29.2790

P/S

5.6307

P/E

55.4242

P/FCF

31.6702

P/OCF

26.9125

P/CF

26.9125

PEG

11.4123

P/S

5.6307

EV Multiple

19.9901

P/FV

29.2790

DPS

11.0100

Latest Headlines (EST)

GlobeNewswire Inc. Jun 23, 05:30 Galapagos benoemt Aaron Cox als Chief Financial Officer The Motley Fool Apr 26, 22:05 4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off The Motley Fool Mar 25, 22:47 Why Pharma and Biotech Stocks Got Thrashed on Tuesday The Motley Fool Mar 08, 15:41 3 Magnificent Growth Stocks to Buy in March The Motley Fool Feb 09, 19:30 3 Fabulous Dividend Stocks to Buy in February GlobeNewswire Inc. Nov 27, 00:30 Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology Benzinga Nov 27, 00:30 Personalized Medicines Market to Surpass Valuation of USD 1352.81 Billion by 2031 | SkyQuest Technology The Motley Fool Nov 16, 13:45 2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious GlobeNewswire Inc. Oct 02, 22:29 Moore Law, PLLC Encourages Amgen, Inc. Investors to Contact Law Firm The Motley Fool Aug 25, 22:30 3 Unstoppable Dividend Stocks to Buy Right Now GlobeNewswire Inc. Aug 12, 21:00 Monoclonal Antibodies Market Size is Surpassing USD 650.49 Billion by 2033, Growing at Projected 12.0% CAGR Zacks Investment Research Jul 24, 14:34 What Lies in Store for Healthcare ETFs in Q2 Earnings? - Zacks Investment Research The Motley Fool May 17, 12:24 Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk The Motley Fool Jan 23, 08:45 This 1 Bullish Move by Merck Could Drive Growth for Years to Come The Motley Fool Jan 23, 06:45 5 Magnificent Dividend Growth Stocks to Buy and Hold Forever Investing.com Jan 17, 07:42 5 'Dogs of the Dow' Stocks Poised to Outshine the Broader Market Once Again The Motley Fool Jan 15, 06:30 5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week The Motley Fool Jan 12, 18:44 Why Vera Therapeutics Stock Soared by 22% This Week

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
2.25 08/16/2024 08/02/2024 08/16/2024 09/06/2024
2.25 05/16/2024 03/06/2024 05/17/2024 06/07/2024
2.25 02/15/2024 12/12/2023 02/16/2024 03/07/2024
2.13 11/16/2023 10/24/2023 11/17/2023 12/08/2023
2.13 08/17/2023 08/01/2023 08/18/2023 09/08/2023
2.13 05/17/2023 03/07/2023 05/18/2023 06/08/2023
2.13 02/14/2023 12/12/2022 02/15/2023 03/08/2023
1.94 11/16/2022 10/28/2022 11/17/2022 12/08/2022
1.94 08/17/2022 08/03/2022 08/18/2022 09/08/2022
1.94 05/16/2022 03/02/2022 05/17/2022 06/08/2022
1.94 02/14/2022 12/03/2021 02/15/2022 03/08/2022
1.76 11/15/2021 10/21/2021 11/16/2021 12/08/2021
1.76 08/16/2021 07/30/2021 08/17/2021 09/08/2021
1.76 05/14/2021 03/03/2021 05/17/2021 06/08/2021
1.76 02/11/2021 12/16/2020 02/15/2021 03/08/2021
1.60 11/13/2020 10/21/2020 11/16/2020 12/08/2020
1.60 08/14/2020 07/23/2020 08/17/2020 09/08/2020
1.60 05/15/2020 03/04/2020 05/18/2020 06/08/2020
1.60 02/13/2020 12/11/2019 02/14/2020 03/06/2020
1.45 11/14/2019 10/22/2019 11/15/2019 12/06/2019
1.45 08/14/2019 08/02/2019 08/15/2019 09/06/2019
1.45 05/16/2019 03/07/2019 05/17/2019 06/07/2019
1.45 02/14/2019 12/07/2018 02/15/2019 03/08/2019
1.32 11/15/2018 10/23/2018 11/16/2018 12/07/2018
1.32 08/16/2018 07/31/2018 08/17/2018 09/07/2018
1.32 05/16/2018 03/07/2018 05/17/2018 06/08/2018
1.32 02/14/2018 12/12/2017 02/15/2018 03/08/2018
1.15 11/16/2017 10/24/2017 11/17/2017 12/08/2017
1.15 08/15/2017 07/31/2017 08/17/2017 09/08/2017
1.15 05/15/2017 03/08/2017 05/17/2017 06/08/2017
1.15 02/13/2017 12/21/2016 02/15/2017 03/08/2017
1.00 11/14/2016 10/17/2016 11/16/2016 12/08/2016
1.00 08/15/2016 07/22/2016 08/17/2016 09/08/2016
1.00 05/13/2016 03/02/2016 05/17/2016 06/08/2016
1.00 02/11/2016 12/16/2015 02/16/2016 03/08/2016
0.79 11/12/2015 10/15/2015 11/16/2015 12/07/2015
0.79 08/13/2015 07/29/2015 08/17/2015 09/08/2015
0.79 05/12/2015 03/05/2015 05/14/2015 06/05/2015
0.79 02/10/2015 12/18/2014 02/12/2015 03/06/2015
0.61 11/10/2014 10/17/2014 11/13/2014 12/05/2014
0.61 08/12/2014 07/25/2014 08/14/2014 09/05/2014
0.61 05/13/2014 03/05/2014 05/15/2014 06/06/2014
0.61 02/11/2014 12/13/2013 02/13/2014 03/07/2014
0.47 11/12/2013 10/16/2013 11/14/2013 12/06/2013
0.47 08/14/2013 07/26/2013 08/16/2013 09/06/2013
0.47 05/14/2013 03/06/2013 05/16/2013 06/07/2013
0.47 02/11/2013 12/14/2012 02/13/2013 03/07/2013
0.36 11/13/2012 10/11/2012 11/15/2012 12/07/2012
0.36 08/14/2012 07/19/2012 08/16/2012 09/07/2012
0.36 05/14/2012 03/15/2012 05/16/2012 06/07/2012
0.36 02/13/2012 12/16/2011 02/15/2012 03/07/2012
0.28 11/15/2011 10/13/2011 11/17/2011 12/08/2011
0.28 08/16/2011 07/29/2011 08/18/2011 09/08/2011